Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Gattex (Teduglutide) for Treatment of Short Bowel Syndrome (SBS)

Drug Name (Brand / Generic)

Gattex / teduglutide

Company / Licensee

NPS Pharmaceuticals / Takeda Pharmaceuticals

Product Description

Human glucagon-like peptide 2 (GLP-2)

Current Indication

Short bowel syndrome (SBS)

Market Sector

Gastroenterology

Development Status

Approved in the US and Europe
Expand
Close
Close
Close

Go Top